Skip to main content

Overview

Dr. Banerjee has over a decade of experience as a biostatistician in biomedical collaborations, which range from randomized clinical trials, observational studies in health services, comparative effectiveness research, “big data” analysis, statistical genetics, and cancer genomics. His methodological research interests are various aspects of mHealth data analysis, in multivariate statistics and its various applications including longitudinal data and repeated measures, and in high-dimensional statistical problems in variable selection and prediction. He has been the primary Biostatistician on 20+ federally funded grants. He is also the Methods Core Director of the Weill Cornell ALACRITY Center (P50 MH113838) where he designs and oversees the analysis of clinical trials and leads the efforts in the development of statistical methodologies using “big” data (electronic health records and health insurance claims), data with multivariate longitudinal outcomes, data from sensors and wearables and brain imaging data (e.g. fMRI). He has served as the statistical mentor of nine fellows and junior faculty and am the primary mentor for three post-doctoral scholars. He is also the founding director of the MS program in Biostatistics and Data Science offered by WCMC. 

Highlights

  1. 1
    Psychological medicine · 2023
    PMID: 37818656DOIFirst author10 citations
  2. 2
    Journal of biomedical informatics · 2021
    PMID: 33933654PMCID: PMC8084618DOISenior author16 citations
  3. 3
    Applied clinical informatics · 2024
    PMID: 39566558PMCID: PMC11578666DOISenior author5 citations

Publications

151 publications

Active

17 grants
  • Sub-PI
    Personalized Response through Integrated Measurement for Depression in Primary care (PRIME-DEP-PC) for Older Adults with Multimorbidity
    National Institute on Aging · 2026–2031 · via Rutgers, The State University of New Jersey – New Brunswick
    K23AG093180-01A1
  • Co-I
    DEPRESCRIBE-HFPEF
    National Institute on Aging · 2025–2029
    R01AG091005-01
  • Co-I
    N-of-1 Trials to Promote Patient-Centered β-blocker Titration in Heart Failure with Reduced Ejection Fraction
    National Institute on Aging · 2025–2029 · via Brigham and Women's Hospital
    P30AG064199-07
  • Co-I
    Understanding Ambulatory Care Utilization in Alzheimer's Disease and Related Dementias (ACUA)
    National Institute on Aging · 2024–2029
    R01AG087243-01
  • Co-I
    Cornell Roybal Center-Translational Research Institute on Pain in Later Life
    National Institute on Aging · 2024–2029
    P30AG022845-23
  • KP
    Emotion Reactivity, Cognitive Reappraisal, and Suicidal Ideation In Middle-aged and Older Adults at High Suicide Risk
    National Institute of Mental Health · 2024–2029
    R01MH134006-01A1
  • Co-I
    I-TRANSFER-HF: Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe: A Type 1 Hybrid Effectiveness Implementation Trial
    National Heart, Lung, and Blood Institute · 2023–2028
    R01HL169312-01
  • Co-I
    Healthier, a Peer Coach Behavioral Intervention to Improve Mental Health in Patients with Rheumatoid Arthritis
    Bristol-Myers Squibb · 2023–2028
    BMSC 226946-01
  • Co-I
    Target Engagement During Social Reward Psychotherapy for Mid- and Late-Life Suicidality: A Precision Imaging Trial
    National Institute of Mental Health · 2023–2028
    R01MH133953-01
  • KP
    Intervention to Reduce Depression Among Elder Abuse Victims: Type 1 Hybrid Trial of Tele-PROTECT
    National Institute of Mental Health · 2023–2028
    R01MH132757-01
  • KP
    A Mobile Intervention for Suicide Prevention For Middle-aged And Older Adults After a Suicide-Related Hospitalization
    National Institute of Mental Health · 2022–2027
    R61MH128516-02
  • Co-I
    REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-4 (REGARDS-MI-4)
    National Heart, Lung, and Blood Institute · 2022–2027
    R01HL165452-01
  • KP
    PATH-Pain: A Primary Care-Based Psychosocial Intervention To Improve Cognitive and Depression Outcomes in Older Adults with MCI and Early Stage AD
    National Institute on Aging · 2021–2027
    R01AG070055-05
  • Co-I
    CKM Among Cancer Survivors: Insights from the REGARDS Study
    American Heart Association · 2026–2027
    26DGCKMCP1645609
  • Co-I
    The COMMUNITY Center to Improve Chronic disease Outcomes through Multi-level and Multigenerational approaches Unifying Novel Interventions and Training for health Equity (Connectome Core)
    National Institute on Minority Health and Health Disparities · 2021–2027 · via Columbia University· 2 renewals
    No publications yet
    P50MD017341-01 CONNECTOME CORE
  • KP
    Center for Research and Education on Aging and Technology Enhancement - CREATE
    National Institute on Aging · 2022–2027
    P01AG073090-01A1
  • Co-I
    Advancing the Conversations Helpful for Awareness of Illness Trajectory (CHAT) Intervention
    National Institute on Aging · 2023–2026
    R21AG077092-01A1
Completed grants (28)
  • KP
    Improving How People Living with Dementia Are Selected for Care Coordination
    National Institute on Aging · 2022–2025 · via Brown University
    U54AG063546-03
  • Co-I
    Novel Approaches to Advance Coordinated Registry Networks (CRNs).
    United States Food & Drug Administration · 2020–2025
    U01FD006936-01
  • Co-I
    Linking VA and non-VA data to study the risk of suicide in chronic pain patients.
    National Institute of Mental Health · 2020–2025
    R01MH121907-01
  • Co-I
    4/4: Leveraging EHR-linked biobanks for deep phenotyping, polygenic risk score modeling, and outcomes analysis in psychiatric disorders
    National Institute of Mental Health · 2019–2025
    R01MH121922-01
  • Co-I
    Predicting Self-Harm, Suicide Attempt, and Suicidal Death using Longitudinal EHR, Claims and Mortality Data
    National Institute of Mental Health · 2019–2025
    R01MH119177-01
  • Co-I
    A telehealth intervention to improve initiation of mental health treatment among depressed older adults with cancer
    National Cancer Institute · 2022–2024 · via Memorial Sloan Kettering Cancer Center
    R21CA270208-01
  • Co-I
    Moving Well: A Peer Coach Intervention for Osteoarthritis Patients Planning Total Knee Arthroplasty
    Rheumatology Research Foundation · 2021–2024
    RRF 194765-01
  • Co-I
    A Novel Cognitive Reappraisal Intervention for Suicide Prevention (R33 Phase)
    National Institute of Mental Health · 2018–2024
    R33MH110542-05
  • KP
    Improving Remote Use of Emotion Regulation Techniques in a Psychosocial Intervention For Older Adults With aMCI
    National Institute on Aging · 2016–2024· 2 renewals
    R01AG050514-05S1
  • Co-I
    Comparative Effectiveness Research to Elucidate Glycemic Control Targets and Optimal Drug Choice for Patients with Type 2 Diabetes at High Risk for COVID-19
    Patient-Centered Outcomes Research Institute · 2020–2023
    CER-2017C3-9230
  • Co-I
    Comparative Effectiveness of Metformin for Type 2 Diabetes with Chronic Kidney Disease
    Patient-Centered Outcomes Research Institute · 2018–2023
    CER-2017C3-9230
  • Co-I
    Using Predictive Models to Improve Care for Hospitalized Patients with Novel Coronavirus Disease
    Patient-Centered Outcomes Research Institute · 2020–2022
    HSD-1604-35187
  • KP
    Creating National Surveillance Infrastructure for Priority Medical Devices
    United States Food & Drug Administration · 2015–2021
    U01FD005478-03
  • KP
    "Safety of Neurohormonal Antagonist Initiation Among Older Adults with Heart Failure Following a Heart Failure Hospitalization"
    American Heart Association · 2018–2021
    18IPA34170185
  • KP
    Economic Evaluation of Medication-Assisted Substance Abuse Treatment
    National Institute on Drug Abuse · 2014–2020
    R01DA035808-04
  • Co-I
    Modeling Social Behavior for Healthcare Utilization in Depression-Supplement
    National Institute of Mental Health · 2016–2020· 2 renewals
    R01MH105384-05S1
  • KP
    1/2 Stepped, Reward-Exposure Based Therapy vs. PST in Late Life Depression
    National Institute of Mental Health · 2014–2020
    R01MH102252-05
  • KP
    Suicide Prevention in Hospitalized Older Adults With MDD and Cognitive Impairment
    American Foundation for Suicide Prevention, Inc. · 2015–2019
    SRG-1-072-14
  • Co-I
    Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients
    New York State Health Foundation · 2017–2019
    17-05047
  • MPI
    Development of statistical methods for identifying digital phenotypes of RDoC constructs
    National Institute of Mental Health · 2018–2019
    P50MH113838-02S1
  • KP
    Reducing Breast Cancer Recurrence Among Black Women: The Breast cancer Weight Loss for Life Study (BWELL)
    Weill Cornell Medical College · 2018–2019
    WCMC 190102-01
  • KP
    MDEpiNet: MCM (Medical Countermeasures)
    United States Food & Drug Administration · 2012–2018
    U01FD004494-01
  • KP
    A Novel Cognitive Reappraisal Intervention for Suicide Prevention
    National Institute of Mental Health · 2016–2018
    R61MH110542-02
  • Co-I
    Quantifying Underuse and Overuse of Knee Replacement
    National Inst of Arthritis & Musculoskeletal & Skin Diseases · 2016–2018 · via Northwestern University· 2 renewals
    R21AR069867-02
  • KP
    Ecosystem Focused Therapy in Post Stroke Depression
    National Institute of Mental Health · 2012–2018
    R01MH096685-04
  • KP
    Suicide Prevention in Cognitively Impaired, Older Adults With Treatment Resistant MDD
    Brain & Behavior Research Foundation · 2014–2018
    22091
  • KP
    Doxycycline for COPD in HIV-Infected Patients
    National Heart, Lung, and Blood Institute · 2012–2017
    R34HL117352-02 EW
  • KP
    Shared Decision-Making for Elderly Depressed Primary Care Patients
    National Institute of Mental Health · 2009–2014
    R01MH084872-05 EW

News mentions